logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/07/2026
Platinum main contract fell 4% intraday, now trading at 398.25 yuan.
Latest
2 m ago
QuestMobile: DouShengSheng user scale approaches Dianping
4 m ago
Olin Biology announced that it has recently noticed some untrue comments on certain online platforms regarding the Phase III clinical trial data of the company's recombinant Staphylococcus aureus vaccine. The 73.25% protection efficacy data disclosed by the company from the Phase III clinical trial results was calculated by an independent third-party statistical team, and the company truthfully made information disclosure based on the report issued by this independent third party. Upon verification, it was found that the data used in the online circulated "Recombinant Staphylococcus aureus Vaccine Phase III Clinical Data Audit Report," such as the number of confirmed cases, total number of subjects, and the conclusions, are inconsistent with the actual situation of the company's clinical trials.
4 m ago
Mega Chipsecurity and Sweet Potato Robotics have reached a strategic cooperation agreement to jointly accelerate the scale development of the physical industry.
5 m ago
The Nikkei 225 index fell further to a 5% decrease.
6 m ago
EOPTOLINK is reportedly planning to submit a Hong Kong listing application of up to $5 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.